Analysts’ Viewpoint on Life Science Reagents Market Scenario
Life science reagents are an integral part of pharmaceutical, biotechnology, life science, and health care industries. The global life science reagents market is expected to witness strong growth during the forecast period due to the increase in application of life science reagents in in vitro diagnostics for the diagnosis of various chronic as well as infectious diseases. Life science reagents are also used to predict disease course, formulate treatment, and monitor the effectiveness of the therapy. Increase in pharmaceutical R&D budgets by governments and private players is likely to support the development of new products and technologies. This is projected to create lucrative revenue opportunities for manufacturers of life science reagents during the forecast period.
Life science reagents are substances or compounds used in a chemical reaction to observe and record changes. Medical researchers analyze this data to determine the cause of a disease. Life science and analytical reagents are used in chemical reactions to measure, detect, or examine other substances. Technological advancements in molecular biology, life sciences, and biotechnology have brought about significant changes in health care diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. This has increased the demand for biotechnology media, sera and reagents, biotechnology reagents, etc. Growth of the life science industry and increase in incidence rate of chronic and infectious diseases are driving the global life science reagents market.
Advances in the health care industry and life sciences industry, improvement in public health measures, and decrease in life-threatening infectious diseases in developed countries are augmenting the life expectancy of the global geriatric population. According to the United Nations, the elderly population (aged 60+ years) is expected to double by 2050 and triple by 2100. The population is likely to rise from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, the geriatric population is growing at a faster rate than the young population. The geriatric population in Asia Pacific and South America is estimated to increase by 300% in the next decade. As part of preventive health care, the geriatric population and people with chronic diseases such as diabetes, respiratory disorders, and cancer regularly require medical tests such as blood tests and urine tests. This is projected to augment the life science reagents market during the forecast period.
Development in the areas of enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques; and their application in the health care industry in disease diagnostics and treatment monitoring are propelling the life science reagents market. For instance, the chemiluminescence immunoassay (CLIA) technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation. Together, these increase the efficiency of the technology to diagnose different types of genetic, chronic, acute, and infectious diseases. Technological advancements in point-of-care (POC) instruments for the diagnosis of various chronic and infectious diseases within a short period, development of high throughput automated immunoassay analyzers, and integration of the various diagnostic techniques in a single system are factors fueling the demand for in vitro diagnostics reagents in the health care industry. Advances in genomics and proteomics have led to the development of newer genetic and protein biomarkers for the diagnosis of cancer and several genetic diseases. Genomic studies are also used in pharmacogenetics and targeted therapy to identify infectious diseases by sequencing reagents to diagnose genetic factors that contribute to common diseases and personalized medicines. Increase in application of cell and tissue culture for the production of monoclonal antibodies, drug development, vaccines, enzymes, growth hormones, and stem cell therapy is propelling the demand for life science reagents.
Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics. Life science reagents, both biological and laboratory chemical reagents, are integral part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop life science tools and reagents for early diagnosis and prevention of disease. As of June 2022, coronavirus (COVID-19) has caused 539 million confirmed infections and 6.3 million deaths. The pandemic does not show any sign of abatement. The impact and consequences of the COVID-19 pandemic positively impacted the life science reagents market in 2020 and 2021. Growth of the diagnostics segment, led by Covid-19 testing and continuous research & development conducted by various pharmaceutical & biotechnological companies to develop medicines and vaccines, is likely to drive the life science reagents market during the forecast period.
In terms of product, the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. The immunoassay reagents segment dominated the global life science reagents market in 2021. The trend is projected to continue during the forecast period. Immunoassay is a highly preferred diagnostic technique used in hospitals and pathology laboratories. The immunoassay technique is increasingly becoming a popular diagnostic tool owing to specific results, high sensitivity, and ease of use.
Based on end-user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others. The hospitals & diagnostic laboratories segment dominated the global life science reagents market in 2021 due to the high usage of life science reagents in hospitals and laboratories for the diagnosis of Covid-19.
North America accounted for the largest share of around 35% of the global life science reagents market in 2021. The market in the region is projected to grow at a CAGR of 5.5% from 2022 to 2031. The life science reagents market in Asia Pacific is anticipated to grow at a higher CAGR during the forecast period due to the large patient pool and rise in investment in health care in countries such as China and India.
The global life science reagents market is fragmented, with the presence of a large number of key players. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.
Each of these players has been profiled in the life science reagents market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Market Size Value in 2021 | US$ 54.7 Bn |
| Market Forecast Value in 2031 | More than US$ 100 Bn |
| Growth Rate | 5.7% |
| Forecast Period | 2022–2031 |
| Historical Data Available for | 2017–2020 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
| Competition Landscape | Market share analysis by company (2021) Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials. |
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global life science reagents market was valued at US$ 54.7 Bn in 2021.
The global life science reagents market is projected to reach more than US$ 100 Bn by 2031.
The global life science reagents market expanded at a CAGR of 11.3% from 2017 to 2021.
The global life science reagents market is anticipated to expand at a CAGR of 5.7% from 2022 to 2031.
Rise in demand for testing & diagnosis due to increase in patient population with infectious and chronic diseases, surge in research & development, and availability of technologically advanced products drive the global market.
The dialysis products segment accounted for more than 30% share of the global life science reagents market in 2021.
North America is expected to account for major share of the global life science reagents market during the forecast period.
Prominent players in the global life science reagents market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Life Science Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Life Science Reagents Market Analysis and Forecast,
2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Life Science Reagents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Chromatography Reagents
6.3.2. Molecular Diagnostic Reagents
6.3.3. Immunoassay Reagents
6.3.4. Clinical Chemistry Reagents
6.3.5. Flow Cytometry Reagents
6.3.6. Cell & Tissue Culture Reagents
6.3.7. Hematology & Hemostasis Reagents
6.3.8. Microbiology Reagents
6.3.9. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Life Science Reagents Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals & Diagnostics Laboratories
7.3.2. Commercial & Contract Research Manufacturers
7.3.3. Academic & Research Institutes
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Life Science Reagents Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Life Science Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017-2031
9.2.1. Chromatography Reagents
9.2.2. Molecular Diagnostic Reagents
9.2.3. Immunoassay Reagents
9.2.4. Clinical Chemistry Reagents
9.2.5. Flow Cytometry Reagents
9.2.6. Cell & Tissue Culture Reagents
9.2.7. Hematology & Hemostasis Reagents
9.2.8. Microbiology Reagents
9.2.9. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals & Diagnostics Laboratories
9.3.2. Commercial & Contract Research Manufacturers
9.3.3. Academic & Research Institutes
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. US
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Life Science Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Chromatography Reagents
10.2.2. Molecular Diagnostic Reagents
10.2.3. Immunoassay Reagents
10.2.4. Clinical Chemistry Reagents
10.2.5. Flow Cytometry Reagents
10.2.6. Cell & Tissue Culture Reagents
10.2.7. Hematology & Hemostasis Reagents
10.2.8. Microbiology Reagents
10.2.9. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals & Diagnostics Laboratories
10.3.2. Commercial & Contract Research Manufacturers
10.3.3. Academic & Research Institutes
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Life Science Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Chromatography Reagents
11.2.2. Molecular Diagnostic Reagents
11.2.3. Immunoassay Reagents
11.2.4. Clinical Chemistry Reagents
11.2.5. Flow Cytometry Reagents
11.2.6. Cell & Tissue Culture Reagents
11.2.7. Hematology & Hemostasis Reagents
11.2.8. Microbiology Reagents
11.2.9. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals & Diagnostics Laboratories
11.3.2. Commercial & Contract Research Manufacturers
11.3.3. Academic & Research Institutes
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user/p>
11.5.3. By Country/Sub-region
12. Latin America Life Science Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Chromatography Reagents
12.2.2. Molecular Diagnostic Reagents
12.2.3. Immunoassay Reagents
12.2.4. Clinical Chemistry Reagents
12.2.5. Flow Cytometry Reagents
12.2.6. Cell & Tissue Culture Reagents
12.2.7. Hematology & Hemostasis Reagents
12.2.8. Microbiology Reagents
12.2.9. Others
12.3. Market Value Forecast By End-user, 2017-2031
12.3.1. Hospitals & Diagnostics Laboratories
12.3.2. Commercial & Contract Research Manufacturers
12.3.3. Academic & Research Institutes
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Life Science Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Chromatography Reagents
13.2.2. Molecular Diagnostic Reagents
13.2.3. Immunoassay Reagents
13.2.4. Clinical Chemistry Reagents
13.2.5. Flow Cytometry Reagents
13.2.6. Cell & Tissue Culture Reagents
13.2.7. Hematology & Hemostasis Reagents
13.2.8. Microbiology Reagents
13.2.9. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals & Diagnostics Laboratories
13.3.2. Commercial & Contract Research Manufacturers
13.3.3. Academic & Research Institutes
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. F. Hoffmann-La Roche AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Danaher Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Abbott
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Siemens Healthineers
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. DiaSorin S.p.A
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Sysmex Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. bioMerieux SA
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Ortho Clinical Diagnostics
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Thermo Fisher Scientific, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. F. Hoffmann-La Roche AG
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Merck KGaA
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Agilent Technologies, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Waters Corporation
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
List of Table
Table 01: Global Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Life Science Reagents Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Life Science Reagents Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Life Science Reagents Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 06: North America Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 09: Europe Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 12: Asia Pacific Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Latin America Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East & Africa Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017-2031
Table 18: Middle East & Africa Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Life Science Reagents Market Size (US$ Mn) Forecast, 2017-2031
Figure 02: Global Life Science Reagents Market Value Share, by Product, 2021
Figure 03: Global Life Science Reagents Market Value Share, by End-user, 2021
Figure 04: Global Life Science Reagents Market Value Share, by Region, 2021
Figure 05: Global Life Science Reagents Market Value Share Analysis (US$ Mn), by Product, 2021 and 2031
Figure 06: Global Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 07: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chromatography Reagents, 2017-2031
Figure 08: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Molecular Diagnostics Reagents, 2017-2031
Figure 09: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay Reagents, 2017-2031
Figure 10: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinical Chemistry Reagents, 2017-2031
Figure 11: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometry Reagents, 2017-2031
Figure 12: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture Reagents, 2017-2031
Figure 13: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology & Hemostasis Reagents, 2017-2031
Figure 14: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbiology Reagents, 2017-2031
Figure 15: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 16: Global Life Science Reagents Market Value Share Analysis (US$ Mn), by End-user, 2021 and 2031
Figure 17: Global Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 18: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostics Laboratories, 2017-2031
Figure 19: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Commercial & Contract Research Manufacturers, 2017-2031
Figure 20: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2017-2031
Figure 21: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 22: Global Life Science Reagents Market Value Share Analysis, by Region, 2021 and 2031
Figure 23: Global Life Science Reagents Market Attractiveness Analysis, by Region, 2022-2031
Figure 24: North America Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 25: North America Life Science Reagents Market Value Share Analysis (US$ Mn), by Country, 2021 and 2031
Figure 26: North America Life Science Reagents Market Attractiveness Analysis, by Country, 2022-2031
Figure 27: North America Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 28: North America Life Science Reagents Market Value Share Analysis, by End-user, 2021and 2031
Figure 29: North America Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 30: North America Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 31: Europe Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 32: Europe Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031
Figure 33: Europe Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 34: Europe Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 35: Europe Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 36: Europe Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 37: Europe Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 38: Asia Pacific Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 39: Asia Pacific Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031
Figure 40: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 41: Asia Pacific Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 42: Asia Pacific Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 43: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 44: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 45: Latin America Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 46: Latin America Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031
Figure 47: Latin America Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 48: Latin America Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 49: Latin America Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 50: Latin America Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 51: Latin America Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 52: Middle East & Africa Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 53: Middle East & Africa Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031
Figure 54: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 55: Middle East & Africa Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031
Figure 56: Middle East & Africa Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031
Figure 57: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by Product, 2022-2031
Figure 58: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by End-user, 2022-2031
Figure 59: Global Life Science Reagents Market Share Analysis, by Company (2021)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Life Science Reagents Market
